211 related articles for article (PubMed ID: 34242571)
1. Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient.
Hill JA; Ujjani CS; Greninger AL; Shadman M; Gopal AK
Cancer Cell; 2021 Aug; 39(8):1037-1038. PubMed ID: 34242571
[No Abstract] [Full Text] [Related]
2. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
5. [The value of booster vaccination against COVID-19].
van Lier PAC; Kalkman S
Ned Tijdschr Geneeskd; 2021 Dec; 165():. PubMed ID: 35138763
[TBL] [Abstract][Full Text] [Related]
6. Heterologous immunization with Covishield and Pfizer vaccines against SARS-CoV-2 elicits a robust humoral immune response.
Ostadgavahi AT; Booth R; Sisson G; McMullen N; Warhuus M; Robertson P; Miller M; Allen WC; El Sherif M; Brownlie R; Falzarano D; Richardson CD
J Infect Dev Ctries; 2021 May; 15(5):653-656. PubMed ID: 34106888
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
Hunter CM; Chou WS; Webb Hooper M
Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
Tscherne A; Schwarz JH; Rohde C; Kupke A; Kalodimou G; Limpinsel L; Okba NMA; Bošnjak B; Sandrock I; Odak I; Halwe S; Sauerhering L; Brosinski K; Liangliang N; Duell E; Jany S; Freudenstein A; Schmidt J; Werner A; Gellhorn Serra M; Klüver M; Guggemos W; Seilmaier M; Wendtner CM; Förster R; Haagmans BL; Becker S; Sutter G; Volz A
Proc Natl Acad Sci U S A; 2021 Jul; 118(28):. PubMed ID: 34162739
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for COVID-19 vaccination in people with rheumatic disease: Developed by the Singapore Chapter of Rheumatologists.
Santosa A; Xu C; Arkachaisri T; Kong KO; Lateef A; Lee TH; Leong KH; Low AHL; Sriranganathan MK; Tan TC; Teng GG; Thong BY; Fong W; Lahiri M
Int J Rheum Dis; 2021 Jun; 24(6):746-757. PubMed ID: 33973379
[TBL] [Abstract][Full Text] [Related]
10. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
[TBL] [Abstract][Full Text] [Related]
11. Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination.
Salzman MB; Huang CW; O'Brien CM; Castillo RD
Emerg Infect Dis; 2021 Jul; 27(7):1944-1948. PubMed ID: 34034858
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccination in Pregnancy: The Benefits Outweigh the Risks.
Chavan M; Qureshi H; Karnati S; Kollikonda S
J Obstet Gynaecol Can; 2021 Jul; 43(7):814-816. PubMed ID: 34253304
[No Abstract] [Full Text] [Related]
13. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
[TBL] [Abstract][Full Text] [Related]
14. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection.
Simon HU; Karaulov AV; Bachmann MF
Int Arch Allergy Immunol; 2020; 181(8):624-628. PubMed ID: 32544911
[TBL] [Abstract][Full Text] [Related]
15. [COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions].
Fallet B; Miauton A; Comte D; Ribi C; Muller YD
Rev Med Suisse; 2021 Apr; 17(733):690-696. PubMed ID: 33830701
[TBL] [Abstract][Full Text] [Related]
16. The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.
Zaqout A; Daghfal J; Alaqad I; Hussein SAN; Aldushain A; Almaslamani MA; Abukhattab M; Omrani AS
Int J Infect Dis; 2021 Jul; 108():116-118. PubMed ID: 33992763
[TBL] [Abstract][Full Text] [Related]
17. Letter to the Editor: Breastfeeding and COVID-19 Vaccine: Yes We Can.
Mayo S; Monfort S
J Hum Lact; 2021 May; 37(2):275-276. PubMed ID: 33724882
[No Abstract] [Full Text] [Related]
18. [Current state of vaccination against SARS-CoV-2].
Iking-Konert C; Specker C; Krüger K; Schulze-Koops H; Aries P
Z Rheumatol; 2021 Mar; 80(2):158-164. PubMed ID: 33528655
[TBL] [Abstract][Full Text] [Related]
19. COVID Arm: Delayed Hypersensitivity Reactions to SARS-CoV-2 Vaccines Misdiagnosed as Cellulitis.
Lindgren AL; Austin AH; Welsh KM
J Prim Care Community Health; 2021; 12():21501327211024431. PubMed ID: 34120504
[TBL] [Abstract][Full Text] [Related]
20. "Let me choose my COVID-19 vaccine".
Dal-Ré R; Stephens R; Sreeharan N
Eur J Intern Med; 2021 May; 87():104-105. PubMed ID: 33581978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
